SVCM
Saturn V Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.69M | Sell |
500,551
-540,729
| -52% | -$5.06M | 1.9% | 19 |
|
|
2025
Q1 | $12.8M | Buy |
1,041,280
+52,752
| +5% | +$648K | 6.46% | 7 |
|
|
2024
Q4 | $13.1M | Buy |
988,528
+486,550
| +97% | +$6.43M | 5.12% | 9 |
|
|
2024
Q3 | $9.66M | Buy |
501,978
+82,324
| +20% | +$1.58M | 3.45% | 12 |
|
|
2024
Q2 | $8.62M | Buy |
419,654
+21,657
| +5% | +$445K | 3.26% | 13 |
|
|
2024
Q1 | $9.47M | Sell |
397,997
-120,802
| -23% | -$2.88M | 3.8% | 13 |
|
|
2023
Q4 | $11.2M | Sell |
518,799
-289,170
| -36% | -$6.25M | 4.29% | 10 |
|
|
2023
Q3 | $11.7M | Buy |
807,969
+634,252
| +365% | +$9.21M | 4.91% | 10 |
|
|
2023
Q2 | $3.64M | Buy |
+173,717
| New | +$3.64M | 2.02% | 17 |
|